AML patients in remission showed the highest frequency of WT1-specific TCRs (nine identified WT1-specific TCRs), compared to healthy individuals and relapsed patients (three and five, respectively), and contained more unique TCRs having a larger TCR repertoire size (Table 2). Here, WT1 is linked to acute myeloid leukemia.